A potent HMG-CoA reductase inhibitor (Ki = 2.3 nM for the active, open ring form of the molecule); a ring hydroxylated metabolite of mevastatin; reduces total plasma cholesterol levels by 29% in dogs when administered at 20 mg/kg per day for five weeks
Size
25 mg
Concentration
n/a
Applications
n/a
Other Names
87068-19-7 103382-8-4 atherosclerosis 3β-hydroxycompactin cholestate eptastatin mevalothin HMGCoA reductase statins CVD pravachol lipostat hydroxymethylglutaryl-coenzyme biosynthetic pathways low high density lipoprotein